Question 1

How will participating in this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB clinical trial (NCT00023400). Contact the study team or your healthcare provider for specific answers.

Question 2

What specific tests or monitoring will I undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB clinical trial (NCT00023400). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of nelfinavir and rifabutin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB clinical trial (NCT00023400). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the results of this trial impact my care for HIV and tuberculosis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB clinical trial (NCT00023400). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with the drug interactions being studied?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB clinical trial (NCT00023400). Contact the study team or your healthcare provider for specific answers.

What this study is about